Home / Pharmaceutical company intelligence
SAFE PHARMACEUTICAL (PVT) LTD logo
Pharmaceutical company intelligence

SAFE PHARMACEUTICAL (PVT) LTD

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi pharmaceutical manufacturer operating since 2006 with a diversified portfolio covering major therapeutic categories.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date13 May 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Safe Pharmaceutical (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
C-I, 20, Sector 6-B, North Karachi, Karachi, Pakistan
Phone
+92 21 36905641-42
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000349 Safe Pharmaceuticals (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000349 136 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx143public portfolio records represented
REG127unique registrations represented
IDX77indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR136current validated price records
G53generic molecules in indexed catalogue
DF7dosage-form groups
TA11therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage95%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage93%
priced packs safely normalized per unit
Comparable-market coverage85%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixSAFE PHARMACEUTICAL (PVT) LTDShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/safe-pharmaceutical-pvt-ltdGenerated 23 Sep 2026Anti-infectives77 · 54%CNS & mental health18 · 13%Pain & musculoskeletal14 · 10%Cardiovascular8 · 6%Gastrointestinal & hepatology8 · 6%Oncology & immunology7 · 5%Hematology & thrombosis3 · 2%Other therapeutic areas8 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioSAFE PHARMACEUTICAL (PVT) LTDDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/safe-pharmaceutical-pvt-ltdGenerated 23 Sep 2026143presentationsInjection55 · 38%Tablet45 · 31%Suspension19 · 13%Capsule14 · 10%Infusion6 · 4%Ointment2 · 1%Other forms2 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionSAFE PHARMACEUTICAL (PVT) LTDCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/safe-pharmaceutical-pvt-ltdGenerated 23 Sep 2026121comparable productsBelow peer median111 · 92%Near peer median3 · 2%Above peer median7 · 6%Company median price position-22.2%Lowest-price equivalents19Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsSAFE PHARMACEUTICAL (PVT) LTDCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/safe-pharmaceutical-pvt-ltdGenerated 23 Sep 2026Mediate Pharmaceutical Pvt Ltd37 shared70% overlapNeutro Pharma (Pvt.) Ltd.,36 shared68% overlapM/s. Genix Pharma (Pvt) Ltd.33 shared62% overlapPharmasol (Pvt) Ltd.33 shared62% overlapZafa Pharmaceutical Laboratories (P…33 shared62% overlapBosch Pharmaceuticals (Pvt) Ltd.32 shared60% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives77 products · 54%
CNS & mental health18 products · 13%
Pain & musculoskeletal14 products · 10%
Cardiovascular8 products · 6%
Gastrointestinal & hepatology8 products · 6%
Oncology & immunology7 products · 5%
Hematology & thrombosis3 products · 2%
Fluids & supportive care3 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins19 products · 13%
Analgesics / NSAIDs12 products · 8%
Antimalarials10 products · 7%
Fluoroquinolone antibacterials9 products · 6%
Benzodiazepines / sedatives8 products · 6%
First-generation cephalosporins7 products · 5%
Oxazolidinone antibacterials7 products · 5%
Macrolide antibacterials6 products · 4%
Formulation footprint

Dosage forms

Injection55 products
Tablet45 products
Suspension19 products
Capsule14 products
Infusion6 products
Ointment2 products
Syrup2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 ZydulidLinezolid 7presentations 100 mg/5 mL, 200 mg/100 mL, 400 mg, 400 mg/200 mL · Suspension, Infusion, Tablet #2 DazDiazepam 6presentations 10 mg, 10 mg/2 mL, 5 mg · Tablet, Injection #3 NekrocinAmikacin 5presentations 100 mg/2 mL, 25 mg/2 mL, 250 mg, 50 mg/2 mL · Injection #4 OceclafCefotaxime 5presentations 0.25 g, 1 g, 1.0 g, 250 mg · Injection #5 TacrolimTacrolimus 5presentations 0.03 %, 0.1 %, 0.5 mg, 1 mg · Ointment, Capsule #6 TorlevaLevetiracetam 5presentations 1 g, 250 mg, 500 mg, 500 mg/5 mL · Tablet, Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median11192% of comparable products
Near market median3within ±5% of median
Above market median76% of comparable products
Lowest-price equivalents19ties included
Company median price position -22.2% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Fosfomycin 1 gFosfomycin · Injection · Vial PKR 57.04/vial/unit-68.1% vs market median Fasigyl 500 mgMetronidazole · IV infusion · 100ml PKR 0.90/mL-50.2% vs market median Bunex 0.2 mgBuprenorphine · Tablet · 50's PKR 12.01/tablet-43.3% vs market median Daz 10 mgDiazepam · Tablet · 1000's PKR 1.47/tablet-41.1% vs market median Daz 5 mgDiazepam · Tablet · 1000's PKR 0.83/tablet-39.0% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 37shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 36shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 33shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 33shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 33shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 32shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers127Distinct registrations among indexed, published, presentation-validated products only
Verified price observations143
Products with a verified price143
Products with multiple price observations0
Source records with multiple versions134
Latest portfolio source check22 Sep 2026
Latest effective price date13 May 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

127 unique registration(s) · 77 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Acevir Aciclovir 200 mg Tablet 1 x 10's Tablet 039418 PKR 300.19 PKR 30.02/tablet 21% below median
Aretemac Artesunate 60 mg Injection 1's 070847 PKR 180.12 PKR 180.12/vial/unit 27% below median
Aretemac Artesunate 30 mg Injection 1's 105366 PKR 108.07 PKR 108.07/vial/unit 27% below median
Aretemac Artesunate 120 mg Injection 1's 105367 PKR 309.62 PKR 309.62/vial/unit 25% below median
Artemate Artemether 80 mg/mL Injection 6's 058223 PKR 900.58 PKR 150.10/vial/unit 19% below median
Artemate 80/480 Artemether + Lumefantrine 80 mg + 480 mg Tablet 4's 081525 PKR 330.21 PKR 82.55/tablet 24% below median
Artemate Plus Artemether 20 mg Tablet 2 x 8's Tablet 058209 PKR 480.31 PKR 30.02/tablet 22% below median
Artemate Plus Artemether + Lumefantrine 40 mg + 240 mg Tablet 1 x 8's 061791 PKR 396.25 PKR 49.53/tablet 23% below median
Azisoft Azithromycin 200 mg/5 mL Dry suspension 15ml Bottle 076633 PKR 247.66 PKR 16.51/mL 22% below median
Azisoft Azithromycin 250 mg Capsule 10's 079978 PKR 382.75 PKR 38.28/capsule 23% below median
Azisoft Azithromycin 500 mg Tablet 6's 083044 PKR 412.77 PKR 68.80/tablet 19% below median
CiproSafe Ciprofloxacin 250 mg Tablet 1 x 10's Tablet 048863 PKR 195.13 PKR 19.51/tablet 23% below median
CiproSafe Ciprofloxacin 500 mg Tablet 1 x 10's Tablet 048864 PKR 322.71 PKR 32.27/tablet 25% below median
CiproSafe Ciprofloxacin 750 mg Tablet 1 x 10's Tablet 048865 PKR 345.22 PKR 34.52/tablet 14% below median
CiproSafe Ciprofloxacin 200 mg/100 mL IV infusion 100ml Vial 048866 PKR 180.12 PKR 1.80/mL 22% below median
Clarinac Clarithromycin 250 mg Tablet 10's 070835 PKR 400.75 PKR 40.08/tablet 16% below median
Clarinac Clarithromycin 500 mg Tablet 10's 070836 PKR 743.06 PKR 74.31/tablet 12% below median
Clarinac Clarithromycin 125 mg/5 mL Suspension 60ml Bottle 076632 PKR 334.71 PKR 5.58/mL 24% below median
Colybid Colistimethate sodium 1 MIU Injection 1's 105370 PKR 2,401.54 PKR 2,401.54/vial/unit 100% above median
Fasigyl Metronidazole 400 mg Tablet 10 x 10's 061779 PKR 225.14 PKR 2.25/tablet 25% below median
Fasigyl Metronidazole (Benzoate) 200 mg/5 mL Suspension 90ml 061780 PKR 72.05 PKR 0.80/mL 19% below median
Fasigyl Metronidazole (Benzoate) 200 mg/5 mL Suspension 60ml 061780 PKR 48.03 PKR 0.80/mL 19% below median
Fasigyl Metronidazole 500 mg IV infusion 100ml 061781 PKR 90.06 PKR 0.90/mL 50% below median
Fitobid Ceftriaxone 250 mg Injection 1 Vial 048879 PKR 151.60 PKR 151.60/vial/unit 21% below median
Fitobid Ceftriaxone 500 mg Injection 1 Vial 048880 PKR 255.16 PKR 255.16/vial/unit 22% below median
Fitobid Ceftriaxone 1 g Injection 1 Vial 048881 PKR 481.81 PKR 481.81/vial/unit 20% below median
Fosfomycin Fosfomycin 1 g Injection Vial 067423 PKR 57.04 PKR 57.04/vial/unit 68% below median
Fosfomycin Fosfomycin 1 g Injection Vial 067424 PKR 119.84 PKR 119.84/vial/unit 19% below median
Fosfomycin Fosfomycin 500 mg Capsule 10's 067425 PKR 150.10 PKR 15.01/capsule 18% below median
LevoSafe Levofloxacin 500 mg/100 mL IV infusion 100ml 048882 PKR 675.43 PKR 6.75/mL 39% above median
LevoSafe Levofloxacin 250 mg Tablet 1 x 10's Tablet 048883 PKR 375.24 PKR 37.52/tablet 22% below median
LevoSafe Levofloxacin 500 mg Tablet 1 x 10's Tablet 048884 PKR 624.40 PKR 62.44/tablet 21% below median
LevoSafe Levofloxacin 750 mg Tablet 1 x 10's Tablet 048885 PKR 750.48 PKR 75.05/tablet 20% below median
Mariquine Chloroquine 50 mg/5 mL Syrup 60ml 058234 PKR 18.01 PKR 0.30/mL 11% below median
Masoquine Amodiaquine 150 mg/5 mL Syrup 20ml 058239 PKR 13.51 PKR 0.68/mL No comparator
Muzelus Moxifloxacin 400 mg Tablet 1 x 5's Tablet 053052 PKR 712.96 PKR 142.59/tablet 23% below median
Nekrocin Amikacin 250 mg Injection 2ml Vial 029465 PKR 131.61 PKR 65.81/mL Near median
Nekrocin Amikacin 500 mg Injection 2ml Vial 029466 PKR 224.70 PKR 112.35/mL 7% below median
Nekrocin Amikacin 25 mg/2 mL Injection 1's 058220 PKR 30.02 PKR 30.02/vial/unit No comparator
Nekrocin Amikacin 50 mg/2 mL Injection 1's 058221 PKR 37.52 PKR 37.52/vial/unit No comparator
Nekrocin Amikacin 100 mg/2 mL Injection 1's 058222 PKR 61.54 PKR 61.54/vial/unit 27% below median
Oceclaf Cefotaxime 250 mg Injection 1 Vial 018368 PKR 85.72 PKR 85.72/vial/unit 19% below median
Oceclaf Cefotaxime 0.25 g Injection 1 Vial 018368 PKR 85.72 PKR 85.72/vial/unit 23% below median
Oceclaf Cefotaxime 500 mg Injection 1 Vial 044023 PKR 129.10 PKR 129.10/vial/unit 19% below median
Oceclaf Cefotaxime 1 g Injection 1 Vial 044024 PKR 232.38 PKR 232.38/vial/unit 19% below median
Oceclaf Cefotaxime 1.0 g Injection 1 Vial 044024 PKR 232.38 PKR 232.38/vial/unit 19% below median
Ozilin Cefazolin 250 mg Injection 1 Vial 039415 PKR 60.04 PKR 60.04/vial/unit 23% below median
Ozilin Cefazolin 500 mg Injection 1 Vial 039416 PKR 90.06 PKR 90.06/vial/unit 28% below median
Ozilin Cefazolin 1 g Injection 1 Vial 039417 PKR 165.11 PKR 165.11/vial/unit 22% below median
Planax Cefixime 100 mg/5 mL Suspension 30ml Bottle 029469 PKR 255.42 PKR 8.51/mL 19% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). SAFE PHARMACEUTICAL (PVT) LTD — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/safe-pharmaceutical-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.